Browse by Audience
Skip to content
Papers of the Week
New diagnostic measures of oxaliplatin-induced peripheral sensory neuropathy.
Authors
Abstract
Oxaliplatin-induced peripheral neuropathy (OIPN) is an unwanted side effect of oxaliplatin chemotherapy treatment. OIPN manifests in an acute phase that lasts a few days after injection and a persistent phase that may become chronic. Currently, there is no consensus about a clinically applicable, quantitative, and objective measure of OIPN.